Pay in 4 interest-free payments of $5.67 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Retatrutide is Eli Lillys once-weekly injectable triple agonist (GLP-1, GIP, and glucagon receptors) still working through Phase 3 trials, with the headline TRIUMPH-4 readout showing roughly 28.7% body-weight reduction at the 12 mg dose over 68 weeks
Kidney and liver function Thyroid markers if indicated Body composition analysis (fat mass vs
330 mcg 3,333 mcg/mL = 0.099 mL (essentially one-tenth of a millilitre)
the recommended duration between discontinuation of the GLP-1 agonist prior to a planned pregnancy
Aftercare Theres no downtime
US$ 25.07
US$ 21.47
US$ 21.12
US$ 29.15
US$ 29.07
US$ 24.46
US$ 22.50
